Physician profile
Raymond Isakov
NPI 1023081221
$5,255.17
in general payments reported to CMS, 2019-2025
21 companies · $1,400 in 2025
The $1,400 reported for 2025 was more than what 79% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $121 · 2022: $497 · 2023: $1,585 · 2024: $1,495 · 2025: $1,400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,480.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,075.22 | 2023-2025 | |
| Mentor Worldwide LLC | $622.06 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Integra Lifesciences Corporation | $525.02 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Musculoskeletal Transplant Foundation INC. | $423.92 | 2022-2024 | |
| Avita Medical Americas, LLC | $406.47 | 2023-2025 | Recell |
| Allergan, INC. | $250.26 | 2022 | |
| Axogen | $184.24 | 2020-2025 | |
| Polynovo North America LLC | $178.70 | 2024-2025 | Novosorb Btm |
| Tela Bio, INC. | $171.05 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| W. L. Gore & Associates, INC. | $169.00 | 2023 | Gore Enform Preperitoneal Biomaterial |
| Aroa Biosurgery Incorporated | $165.78 | 2024 | |
| Smith+Nephew, INC. | $156.93 | 2019 | |
| Dilon Technologies, INC. | $145.55 | 2023-2024 | Hemoblast Bellows |
| Baxter Healthcare | $144.71 | 2025 | Artiss |
| Organogenesis INC. | $124.06 | 2023 | Puraply |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $123.74 | 2023 | |
| Biotissue Holdings INC. | $121.92 | 2024 | |
| Teleflex LLC | $112.15 | 2023 | Quikclot |
| Boston Scientific Corporation | $75.81 | 2024 | Spyglass Discover |
| Ethicon US, LLC | $47.18 | 2024-2025 | Stratafix, Ethicon, Dermabond Prineo |
| Solventum Corporation | $31.40 | 2025 | Activ.A.C., Prevena, V.A.C.Instill |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Isakov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.